G1 THERAPEUTICS INC shareholders Q3 2023

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
CREATIVE FINANCIAL DESIGNS INC /ADV 17,805$25,6390.00%
GSA CAPITAL PARTNERS LLP 19,366$280.00%
Connor, Clark & Lunn Investment Management Ltd. 204,200$294,0480.00%
SIGNATUREFD, LLC 44,487$64,0610.00%
MARSHALL WACE, LLP 516,728$744,0890.00%
RAYMOND JAMES & ASSOCIATES 925,776$1,333,1170.00%
Tortoise Investment Management, LLC 2,988$4,3030.00%
D. E. Shaw & Co., Inc. 505,082$727,3180.00%
Renaissance Technologies 474,080$6830.00%
China Universal Asset Management Co., Ltd. 1,331$20.00%
External links

This page lists G1 THERAPEUTICS INC's shareholders in Q3 2023. To view G1 THERAPEUTICS INC's shareholder history, click here.